Optimization of nanostructured lipid carriers for lutein delivery

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 353, Issue 2-3, 2010, Pages 149-156

  Liu, Chi Hsien ^a   Wu, Chao Ting ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Lutein; Nanostructured lipid carriers; Optimization; Response surface methodology

Indexed keywords

DIFFERENTIAL SCANNING CALORIMETRY; KETONES; LEAKAGE (FLUID); PHOTON CORRELATION SPECTROSCOPY; POLYDISPERSITY; SURFACE ACTIVE AGENTS; SURFACE PROPERTIES; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CENTRAL COMPOSITE DESIGNS; CRYSTALLINE LATTICE; DIFFUSION CELLS; DRUG LOAD; GASTRIC FLUIDS; HYDROPHILIC SURFACTANTS; INTESTINAL FLUID; LIPOPHILIC DRUGS; LUTEIN; NANOSTRUCTURED LIPID CARRIERS; PHYLLOQUINONE; PLURONICS; POLYDISPERSIONS; RELEASE RATE; RESPONSE SURFACE METHODOLOGY; SPHERICAL MORPHOLOGIES; SUSTAINED-RELEASE; TEM; ULTRA-SONICATION;

OPTIMIZATION;

GLYCEROL OLEATE; GLYCEROL PALMITOSTEARATE; POLOXAMER; SOLID LIPID NANOPARTICLE; XANTHOPHYLL;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HUMAN CELL; HYDROPHILICITY; INTESTINE FLUID; LIPOPHILICITY; LOAD CARRYING CAPACITY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; RESPONSE SURFACE METHOD; STOMACH JUICE; SUSTAINED RELEASE PREPARATION; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 71649087412     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2009.11.006     Document Type: Article

References (49)

1. Wong H.L., Bendayan R., Rauth A.M., Li Y., and Wu X.Y. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv. Drug Deliv. Rev. 59 (2007) 491-504
2. Müller R.H., Petersen R.D., Hommoss A., and Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev. 59 (2007) 522-530
3. Wissing S., and Müller R. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int. J. Pharm. 242 (2002) 377-379
4. Schäfer-Korting M., Mehnert W., and Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug. Deliv. Rev. 59 (2007) 427-443
5. Uner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie 61 (2006) 375-386
6. Han F., Li S., Yin R., Liu H., and Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surf. A: Physicochem. Eng. Asp. 315 (2008) 210-216
7. Lin X., Li X., Zheng L., Yu L., Zhang Q., and Liu W. Preparation and characterization of monocaprate nanostructured lipid carriers. Colloids Surf. A: Physicochem. Eng. Asp. 311 (2007) 106-111
8. Xia Q., Hao X., Lu Y., Xu W., Wei H., Ma Q., and Gu N. Production of drug-loaded lipid nanoparticles based on phase behaviors of special hot microemulsions. Colloids Surf. A: Physicochem. Eng. Asp. 313-314 (2008) 27-30
9. Hentschel A., Gramdorf S., Müller R.H., and Kurz T. β-Carotene-loaded nanostructured lipid carriers. J. Food Sci. 73 (2008) N1-N6
10. Teeranachaideekul V., Müller R.H., and Junyaprasert V.B. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability. Int. J. Pharm. 340 (2007) 198-206
11. Mehnert W., and Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001) 165-196
12. Abu-Izza K.A., García-Contreras L., and Lu D.R. Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology. J. Pharm. Sci. 85 (1996) 144-149
13. Mirhosseini H., Tan C.P., Hamid N.S.A., and Yusof S. Effect of Arabic gum, xanthan gum and orange oil contents on zeta-potential, conductivity, stability, size index and pH of orange beverage emulsion. Colloids Surf. A: Physicochem. Eng. Asp. 315 (2008) 47-56
14. Pey C.M., Maestro A., Sole I., Gonzalez C., Solans C., and Gutierrez J.M. Optimization of nano-emulsions prepared by low-energy emulsification methods at constant temperature using a factorial design study. Colloids Surf. A: Physicochem. Eng. Asp. 288 (2006) 144-150
15. Taha E.I., Samy A.M., Kassem A.A., and Khan M.A. Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Pharm. Dev. Technol. 10 (2005) 363-370
16. ®) for oral drug delivery. Drug Dev. Ind. Pharm. 34 (2008) 1394-1405
17. Porter C.J.H., Pouton C.W., Cuine J.F., and Charman W.N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug. Deliv. Rev. 60 (2008) 673-691
18. Barnes H.T., and Roberts R.L. Lutein. Part II. Designing foods and beverages for healthy skin. Agro. Food Ind. Hi. Technol. 16 (2005) 43-45
19. Olmedilla B., Granado F., Blanco I., and Vaquero M. Lutein, but not [alpha]-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition 19 (2003) 21-24
20. Richer S., Stiles W., Statkute L., Pulido J., Frankowski J., Rudy D., Pei K., Tsipursky M., and Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75 (2004) 216-230
21. Lornejad-Schäfer M.R., Lambert C., Breithaupt D.E., Biesalski H.K., and Frank J. Solubility, uptake and biocompatibility of lutein and zeaxanthin delivered to cultured human retinal pigment epithelial cells in tween 40 micelles. Eur. J. Nutr. 46 (2007) 79-86
22. O'Sullivan S.M., Woods J.A., and O'Brien N.M. Use of Tween 40 and Tween 80 to deliver a mixture of phytochemicals to human colonic adenocarcinoma cell (CaCo-2) monolayers. Br. J. Nutr. 91 (2004) 757-764
23. Hu F.Q., Hong Y., and Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int. J. Pharm. 273 (2004) 29-35
24. Wissing S.A., and Müller R.H. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J. Control. Release 81 (2002) 225-233
25. García-Fuentes M., Torres D., and Alonso M.J. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf. B: Biointerfaces 27 (2003) 159-168
26. Venkateswarlu V., and Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release 95 (2004) 627-638
27. Martini S., and Herrera M.L. Physical properties of shortenings with low-trans fatty acids as affected by emulsifiers and storage conditions. Eur. J. Lipid Sci. Technol. 110 (2008) 172-182
28. Vivek K., Reddy H., and Murthy R.S.R. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS Pharm. Sci. Technol. 8 (2007)
29. Han F., Li S., Yin R., Liu H., and Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surf. A: Physicochem. Eng. Asp. 315 (2008) 210-216
30. ® EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. Pharm. Res. 20 (2003) 1085-1092
31. Zhang Y., and Benet L.Z. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet. 40 (2001) 159-168
32. Liversidge G.G., and Conzentino P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int. J Pharm. 125 (1995) 309-313
33. Kogan A., and Garti N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 123-126 (2006) 369-385
34. Heurtault B., Saulnier P., Pech B., Proust J.-E., and Benoit J.-P. Physico-chemical stability of colloidal lipid particles. Biomaterials 24 (2003) 4283-4300
35. Kentish S., Wooster T.J., Ashokkumar M., Balachandran S., Mawson R., and Simons L. The use of ultrasonics for nanoemulsion preparation. Inno. Food Sci. Emerg. Technol. 9 (2008) 170-175
36. Schwarz C. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release 30 (1994) 83-96
37. Blasi P., Giovagnoli S., Schoubben A., Ricci M., and Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv. Drug Deliv. Rev. 59 (2007) 454-477
38. Jores K., Mehnert W., Drechsler M., Bunjes H., Johann C., and Mäder K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Release 95 (2004) 217-227
39. Siekmann B., and Westesen K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur. J. Pharm. Biopharm. 42 (1996) 104-109
40. Truong Cong T., Faivre V., Nguyen T.T., Heras H., Pirot F., Walchshofer N., Sarciron M.E., and Falson F. Study on the hydatid cyst membrane: permeation of model molecules and interactions with drug-loaded nanoparticles. Int. J. Pharm. 353 (2008) 223-232
41. Trevaskis N.L., Charman W.N., and Porter C.J.H. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv. Drug Deliv. Rev. 60 (2008) 702-716
42. Khoo S.M., Shackleford D.M., Porter C.J.H., Edwards G.A., and Charman W.N. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm. Res. 20 (2003) 1460-1465
43. Parker R.S. Absorption, metabolism, and transport of carotenoids. FASEB J. 10 (1996) 542-551
44. Toyoda Y., Thomson L.R., Langner A., Craft N.E., Garnett K.M., Nichols C.R., Cheng K.M., and Dorey C.K. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1210-1221
45. Chitchumroonchokchai C., Schwartz S.J., and Failla M.L. Assessment of lutein bioavailability from meals and a supplement using simulated digestion and Caco-2 human intestinal cells. J. Nutr. 134 (2004) 2280-2286
46. Champagne C.P., and Fustier P. Microencapsulation for the improved delivery of bioactive compounds into foods. Curr. Opin. Biotechnol. 18 (2007) 184-190
47. Teeranachaideekul V., Boonme P., Souto E.B., Müller R.H., and Junyaprasert V.B. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J. Control. Release 128 (2008) 134-141
48. Acosta E. Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Curr. Opin. Colloid Interface Sci. 14 (2009) 3-15
49. Schenk D.J., Jones A.N., Braun M.P., Yao D., Wallace M.A., Marques R., Jenkins H.J., Chang A., Jia X., Crocker L.S., Dean D.C., and Melillo D.G. Ultrasonic particle size reduction of radiolabeled pharmaceuticals. J. Label. Comp. Radiopharm. 47 (2004) 399-406